ArcherDX analysis credits for BWC come from Integrated DNA Technologies
- Birmingham Women's and Children's NHS Foundation Trust
- West Midlands
- Below threshold - without competition
- 1 August 2026 to 31 July 2027
Birmingham Women's and Children's NHS Foundation Trust is buying ArcherDX analysis credits for its cancer service from Integrated DNA Technologies.
The credits give the trust's cancer testing continued access to proprietary analysis pipelines on ArcherDX genomic sequencing platforms.
The trust awarded the £50,000 contract directly in June 2026. It runs for a year, to July 2027.
Contract ends July 2027
- What
- Genomic data platforms and bioinformatics
- Supplier
- Integrated DNA Technologies
- Value
- £50,000
- How it was bought
- Below threshold - without competition
- Dates and next
- Aug 2026 to Jul 2027